Stay updated with breaking news from Activity Impairment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mind Medicine Inc. , , a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it will present detailed results from its...
Incremental improvements in patient-reported outcomes are linked to enhancements in work productivity and daily life in individuals with AS.
While past studies have shown the connection between poor sleep and job performance, this research dives deeper into the experience of this specific population.
This web-based research is the first conducted to assess the burden of disease and treatment satisfaction among those in Japan with PN.
This new analysis on IBD patients initiating biologic therapy with the biosimilar ABP 501 indicates that the drug’s lower cost and efficacy may lead to greater use.